Pulmonary embolism Trials in Beijing, China
Conditions / Pulmonary embolism / Beijing, China
Research into Pulmonary embolism spans multiple therapeutic approaches and trial phases.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00796692 | Nadroparin for the Initial Treatment of Pulmonary Thromboembolism | COMPLETED | PHASE4 |
| NCT05171049 | A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | TERMINATED | PHASE3 |
| NCT00439777 | Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study | COMPLETED | PHASE3 |
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | COMPLETED | PHASE3 |
| NCT05171075 | A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | TERMINATED | — |
| NCT05171075 | A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | TERMINATED | — |
| NCT00423319 | Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) | COMPLETED | PHASE3 |
| NCT00452530 | Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery | COMPLETED | PHASE3 |
| NCT06727669 | Longitudinal Cohort of Thrombosis and Hemostasis Diseases | RECRUITING | — |
| NCT01610141 | Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients | UNKNOWN | PHASE4 |